![Dana Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Lee
Corporate Officer/Principal bei
PHARMACYCLICS, INC.
Profil
Dana Lee is currently Vice President-Drug Safety at Pharmacyclics LLC since 2013.
Formerly, Dr. Lee was Senior Director-Pharmacovigilance Division at Amylin Pharmaceuticals, Inc. in 2011 and Vice President-Medical Affairs at Mast Therapeutics, Inc. in 2012.
Dr. Lee earned a doctorate from The University of California, San Francisco.
Aktive Positionen von Dana Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 01.02.2013 |
Ehemalige bekannte Positionen von Dana Lee
| Unternehmen | Position | Ende |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Dana Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
